Provider Profile
Listed in the NPI registry as a nurse practitioner, Kyleigh Hart, APRN practices in Tampa, FL. Medicare claims data shows Kyleigh provided 33,513 services to 392 patients. The services billed most often include injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), injection, tocilizumab, 1 mg, and injection, golimumab, 1 mg, for intravenous use.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
12902 USF MAGNOLIA DR
Tampa, FL 33612
5985 Silver Falls Run Ste 200
Bradenton, FL 34211
600 N Cattlemen Rd Ste 200
Sarasota, FL 34232
33,513 services · 392 patients · 10 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
32 | As often as other peers in Nurse Practitioner |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
133 | More often than most peers in Nurse Practitioner |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
100 | More often than most peers in Nurse Practitioner |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0717 |
11,800 | Less often than most peers in Nurse Practitioner |
| Injection, tocilizumab, 1 mg | Drug given | J3262 |
6,640 | Too few peers to compare |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
5,750 | Too few peers to compare |
| Injection, secukinumab, intravenous, 1 mg | Drug given | J3247 |
5,231 | Too few peers to compare |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
2,875 | Less often than most peers in Nurse Practitioner |
| Injection, denosumab, 1 mg | Drug given | J0897 |
900 | Less often than most peers in Nurse Practitioner |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
52 | As often as other peers in Nurse Practitioner |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Kyleigh Hart is a nurse practitioner in Tampa, FL. That is the designation recorded for this NPI in the federal registry.
NPI registry
Kyleigh Hart is listed at 12902 Usf Magnolia Dr, Tampa, FL 33612. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (813) 745-7365. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Kyleigh Hart's National Provider Identifier is 1760085195. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Kyleigh Hart attended Other, graduating in 2020. This comes from the CMS National Downloadable File.
CMS public data
Kyleigh Hart has 6 years experience. Calculated from a graduation year of 2020, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Kyleigh Hart performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Kyleigh Hart. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.